chr4-148299958-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000901.5(NR3C2):c.1758-39841C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.784 in 152,078 control chromosomes in the GnomAD database, including 46,933 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.78 ( 46933 hom., cov: 31)
Consequence
NR3C2
NM_000901.5 intron
NM_000901.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.55
Publications
2 publications found
Genes affected
NR3C2 (HGNC:7979): (nuclear receptor subfamily 3 group C member 2) This gene encodes the mineralocorticoid receptor, which mediates aldosterone actions on salt and water balance within restricted target cells. The protein functions as a ligand-dependent transcription factor that binds to mineralocorticoid response elements in order to transactivate target genes. Mutations in this gene cause autosomal dominant pseudohypoaldosteronism type I, a disorder characterized by urinary salt wasting. Defects in this gene are also associated with early onset hypertension with severe exacerbation in pregnancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
NR3C2 Gene-Disease associations (from GenCC):
- autosomal dominant pseudohypoaldosteronism type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- pseudohyperaldosteronism type 2Inheritance: AD, Unknown Classification: LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.823 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.784 AC: 119134AN: 151960Hom.: 46891 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
119134
AN:
151960
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.784 AC: 119236AN: 152078Hom.: 46933 Cov.: 31 AF XY: 0.782 AC XY: 58146AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
119236
AN:
152078
Hom.:
Cov.:
31
AF XY:
AC XY:
58146
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
32643
AN:
41488
American (AMR)
AF:
AC:
12105
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
2833
AN:
3472
East Asian (EAS)
AF:
AC:
4350
AN:
5156
South Asian (SAS)
AF:
AC:
3906
AN:
4814
European-Finnish (FIN)
AF:
AC:
7445
AN:
10556
Middle Eastern (MID)
AF:
AC:
255
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53216
AN:
67984
Other (OTH)
AF:
AC:
1650
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1337
2674
4010
5347
6684
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2866
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.